| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |